Myxoid synovial sarcoma: An underappreciated morphologic subset

Modern Pathology

Volumn 12, Issue 5, 1999, Pages 456-462

  Krane, Jeffrey F ^a   Bertoni, Franco ^b   Fletcher, Christopher D M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Immunohistochemistry; Malignant peripheral nerve sheath tumor; Myxoid change; Sarcoma; Soft tissue; Synovial sarcoma

Indexed keywords

ALCIAN BLUE; ALPHA ACTIN; CD99 ANTIGEN; DESMIN; EPITHELIAL MEMBRANE ANTIGEN; KERATIN; PROTEIN S 100;

ADOLESCENT; ADULT; AGE; ARTICLE; CALCIFICATION; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMANGIOPERICYTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MALE; MAST CELL; MYXOSARCOMA; NERVE SHEATH TUMOR; PRIORITY JOURNAL; SCHOOL CHILD; SPINDLE CELL SARCOMA; STROMA CELL; SYNOVIAL SARCOMA; TUMOR VOLUME;

ADOLESCENT; ADULT; CHILD; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MYXOSARCOMA; SARCOMA, SYNOVIAL; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0032894897     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Majeste RM, Beckman EN. Synovial sarcoma with an overwhelming epithelial component. Cancer 1988;61:2527-31.
2. Weidner N, Goldman R, Johnston J. Epithelioid monophasic synovial sarcoma. Ultrastruct Pathol 1993;17:287-94.
3. Enzinger FM, Weiss SW. Synovial sarcoma. In: Soft tissue tumors. 3rd ed. St. Louis: Mosby; 1995. p. 757-86.
4. King ESJ. Tissue differentiation in malignant synovial tumors. J Bone Joint Surg 1952;34B:97-115.
5. Moffatt EJ, Liu K, Layfield LJ. Demonstration of myxoid change in fine-needle aspiration of synovial sarcoma: a case report. Diagn Cytopathol 1998;18:188-91.
6. Kampe CE, Rosen G, Eilber F, Eckardt J, Lowenbraun S, Foster J, et al. Synovial sarcoma: a study of intensive chemotherapy in 14 patients with localized disease. Cancer 1993;72:2161-9.
7. Ladenstein R, Treuner J, Koscielniak E, d'Oleire F, Keim M, Gadner H, et al. Synovial sarcoma of childhood and adolescence: report of the German CWS-81 study. Cancer 1993;71: 3647-55.
8. Rosen G, Forscher C, Lowenbraun S, Eilber F, Eckardt J, Holmes C, et al. Synovial sarcoma: uniform response of metastases to high-dose ifosfamide. Cancer 1994;73:2506-11.
9. Bokemeyer C, Franzke A, Hartmann JT, Schober C, Arseniev L, Metzner B, et al. A phase I/II study of sequential, dose-escalated, high-dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas. Cancer 1997;80:1221-7.
10. MIC2 (CD99) in synovial sarcoma. Appl Immunohistochem 1995;3:168-73.
11. Guillou L, Wadden C, Kraus MD, Dei Tos AP, Fletcher CD. S-100 protein reactivity in synovial sarcomas: a potentially frequent diagnostic pitfall. Immunohistochemical analysis of 100 cases. Appl Immunohistochem 1996;4:167-75.
12. Fisher C, Schofield JB. S-100 protein-positive synovial sarcoma. Histopathology 1991;19:375-7.
13. Lopes JM, Bjerkehagen B, Holm R, Bruland O, Sobrinho-Simoes M, Nesland JM. Immunohistochemical profile of synovial sarcoma with emphasis on the epithelial-type differentiation: a study of 49 primary tumours, recurrences, and metastases. Pathol Res Pract 1994;190:168-77.
14. Ordóñez NG, Mahfouz SM, Mackay B. Synovial sarcoma: an immunohistochemical and ultrastructural study. Hum Pathol 1990;21:733-49.
15. Schmidt D, Thum P, Harms D, Treuner J. Synovial sarcoma in children and adolescents: a report from the Kiel Pediatric Tumor Registry. Cancer 1991;67:1667-72.
16. Fetsch JF, Meis JM. Synovial sarcoma of the abdominal wall. Cancer 1993;72:469-77.
17. Salisbury JR, Isaacson PG. Synovial sarcoma: an immunohistochemical study. J Pathol 1985;147:49-57.
18. Gray MH, Rosenberg AE, Dickersin GR, Bhan AK. Glial fibrillary acid protein and keratin expression by benign and malignant nerve sheath tumors. Hum Pathol 1989;20:1089-96.
19. Schmidt D, Harms D. The applicability of immunohistochemistry in the diagnosis and differential diagnosis of malignant soft tissue tumors: a re-evaluation based on the material of the Kiel Pediatric Tumor Registry. Klin Padiatr 1990;202:224-9.
20. Hirose T, Hasegawa T, Kudo E, Seki K, Sano T, Hizawa K. Malignant peripheral nerve sheath tumors: an immunohistochemical study in relation to ultrastructural features. Hum Pathol 1992;23:865-70.
21. Miettinen M. Keratin subsets in spindle cell sarcomas: keratins are widespread but synovial sarcoma contains a distinctive keratin polypeptide pattern and desmoplakins. Am J Pathol 1991;138:505-13.
22. Meis JM, Enzinger FM, Martz KL, Neal JA. Malignant peripheral nerve sheath tumors (malignant schwannomas) in children. Am J Surg Pathol 1992;16:694-707.
23. Renwick PJ, Reeves BR, Dal Cin P, Fletcher CD, Kempski H, Sciot R, et al. Two categories of synovial sarcoma defined by divergent chromosome translocation breakpoints in Xp11.2, with implications for the histologic sub-classification of synovial sarcoma. Cytogenet Cell Genet 1995;70:58-63.
24. Singer S, Baldini EH, Demetri GD, Fletcher JA, Corson JM. Synovial sarcoma: prognostic significance of tumor size, margin of resection, and mitotic activity for survival. J Clin Oncol 1996;14:1201-8.